Merck Aktie

127,47USD -0,26USD -0,20%
Merck für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A0YD8Q / ISIN: US58933Y1055
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,88
The Vanguard Group, Inc. 9,66
Vanguard Group, Inc. (Subfiler) 9,16
State Street Corp. 4,64
Wellington Management Co. LLP (Wellington Breakout) 3,19
Vanguard Total Stock Market ETF 3,16
BlackRock Fund Advisors 2,83
Vanguard 500 Index Fund 2,57
Geode Capital Management LLC 2,23
BlackRock Institutional Trust Co. NA 2,23
Fidelity Management & Research Co. LLC 1,59
Fidelity 500 Index Fund 1,22
SPDR S&P 500 ETF Trust 1,18
Norges Bank (13F) 1,13
Government Pension Fund - Global (The) 1,10

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 71 000 74 000 68 000 69 000 72 000
Umsatz pro Mitarbeiter in Mio. EUR 0,66 0,65 0,72 0,85 0,83

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 27 483 27 764 30 266 35 722 32 168
Summe Anlagevermögen 53 257 58 770 72 815 77 976 73 849
Summe Aktiva 84 397 91 588 105 694 109 160 106 675

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 27 350 33 453 34 631 31 985 36 268
Summe Fremdkapital 58 396 66 184 67 437 63 102 69 040
Summe Eigenkapital 26 001 25 404 38 257 46 058 37 635
Summe Passiva 84 397 91 588 105 694 109 160 106 675

Adresse

126 East Lincoln Avenue, 07065 Rahway
Telefon +1 (908) 740-4000
Internet http://www.merck.com

Management

Allan Gabor
President-Asian-Pacific-BioPharma Business
Andre Musto
SVP & Head-Gbl Cardiometabolic & Endoc Franchise
Betty D. Larson
Chief Human Resources Officer & Executive VP
Brooke Hinkson
Executive Director-Global Clinical Data Standards
Carol Bowden
Med Aff. Dir, Cardiovascular Metabolism, NorCal
Caroline A. Litchfield
Chief Financial Officer & Executive Vice President
Chirfi Guindo
Chief Marketing Officer-Human Health & SVP
Christine E. Seidman
Independent Director
Dalton E. Smart
Senior Vice President-Finance & Global Controller
Dave Williams
Chief Information & Digital Officer
Dean Y. Li
EVP & President-Merck Research Laboratories
Denise Williams
Vice President
Douglas M. Baker
Independent Director
Eric H. Rubin
Senior VP-Global Clinical Oncology
Fiona Hamilton Marshall
Senior VP & Global Head-Discovery Sciences
Inge G. Thulin
Independent Director
James Matteucci
Associate Director-State Government Affairs
Jannie Oosthuizen
President-Merck Human Health
Jennifer Zachary
Executive Vice President & General Counsel
Johanna Herrmann
Vice President-Global Communications
Joseph Romanelli
President-Human Health International
Kathy J. Warden
Independent Director
Kelly E. W. Grez
Secretary
Mary Ellen Coe
Independent Director
Michael Klobuchar
Chief Strategy Officer & Executive Vice President
Pamela J. Craig
Independent Director
Patricia Fiorello Russo
Independent Director
Paul B. Rothman
Independent Director
Peter Dannenbaum
Vice President-Investor Relations
Richard R. DeLuca
Executive Vice President & President-Animal Health
Risa J. Lavizzo-Mourey
Independent Director
Robert M. Davis
Chairman, President & Chief Executive Officer
Sanat Chattopadhyay
EVP & President-Merck Manufacturing Division
Stephen L. Mayo
Independent Director
Sylvia A. Ayler
Legal Director
Thomas Henry Glocer
Lead Independent Director